agnosis difficult as mentioned before. Therefore, we think that two more borders could be drawn in Figure 1A as follows: (1) line "b" can be drawn horizontally from the intersection of the caudal margin of the innominate vein to the right margin of the trachea and (2) line "c" can be drawn horizontally from the caudal point of confluence of the innominate vein and the superior vena cava (SVC). However, there would be drawbacks to using both these lines too, even though they are horizontal. In the case of line "b," the required intersection point through which this line passes would be absent in cases where the left margin of the SVC overlaps with the trachea. For line "c," there would be some difficulties in identifying the point of confluence of the innominate vein with the SVC. These difficulties can be overcome if it is clarified whether the lymph node illustrated in Figure 1B is level 2R or level 4R. We hope the IASLC will help us bridge the information gap between the sixth and seventh editions of the TNM classification for lung cancer.
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